• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[人口医学与价值医疗的简要介绍]

[Brief introduction of population medicine and value-based healthcare].

作者信息

Liu X, Zhan Y L, Yue H X, Qu Y M, Jiang Y, Gray Muir

机构信息

School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.

Value Based Healthcare Programme, University of Oxford, Oxford OX2 6GG, United Kingdom.

出版信息

Zhonghua Liu Xing Bing Xue Za Zhi. 2021 May 10;42(5):923-927. doi: 10.3760/cma.j.cn112338-20210111-00025.

DOI:10.3760/cma.j.cn112338-20210111-00025
PMID:34814490
Abstract

Three healthcare revolutions and four medical paradigm shifts have had a profound impact on the development of healthcare system, which has greatly improved human health, however, the COVID-19 pandemic has exposed hidden dangers and problems in the construction of the healthcare system. In this paper, we made a brief introduction of population medicine and value-based healthcare for the purpose of suggesting new ideas and directions for the future development of healthcare system.

摘要

三次医疗保健革命和四次医学范式转变对医疗保健系统的发展产生了深远影响,极大地改善了人类健康。然而,新冠疫情暴露了医疗保健系统建设中存在的隐患和问题。在本文中,我们简要介绍了群体医学和基于价值的医疗保健,旨在为医疗保健系统的未来发展提出新思路和方向。

相似文献

1
[Brief introduction of population medicine and value-based healthcare].[人口医学与价值医疗的简要介绍]
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 May 10;42(5):923-927. doi: 10.3760/cma.j.cn112338-20210111-00025.
2
[COVID-19 pandemic: Experience and impact in an intermediate healthcare center of Tarragona].[新冠疫情:塔拉戈纳一家中级医疗中心的经验与影响]
Rev Esp Geriatr Gerontol. 2022 Jul-Aug;57(4):237-238. doi: 10.1016/j.regg.2022.07.001. Epub 2022 Jul 18.
3
SARS-CoV-2 Infection in Healthcare Professionals and General Population During "First Wave" of COVID-19 Pandemic: A Cross-Sectional Study Conducted in Sicily, Italy.新冠疫情“第一波”期间医护人员和普通人群中的新型冠状病毒2型感染:在意大利西西里岛进行的一项横断面研究
Front Public Health. 2021 May 13;9:644008. doi: 10.3389/fpubh.2021.644008. eCollection 2021.
4
Low-value health care in the COVID-19 pandemic.新冠疫情期间的低价值医疗服务。
Lancet Glob Health. 2021 Sep;9(9):e1214. doi: 10.1016/S2214-109X(21)00354-5.
5
Low-value health care in the COVID-19 pandemic.新冠疫情期间的低价值医疗服务
Lancet Glob Health. 2021 Sep;9(9):e1213. doi: 10.1016/S2214-109X(21)00353-3.
6
[Antibody Screening and Risk Assessment of Healthcare Professionals in the COVID-19 Pandemic].[新冠疫情期间医护人员的抗体筛查与风险评估]
Mikrobiyol Bul. 2021 Jul;55(3):357-373. doi: 10.5578/mb.20219806.
7
The Capacity of the Indonesian Healthcare System to Respond to COVID-19.印度尼西亚医疗保健系统应对新冠疫情的能力。
Front Public Health. 2021 Jul 7;9:649819. doi: 10.3389/fpubh.2021.649819. eCollection 2021.
8
COVID-19 and Healthcare Facilities: a Decalogue of Design Strategies for Resilient Hospitals.新型冠状病毒肺炎与医疗设施:韧性医院设计策略十诫
Acta Biomed. 2020 Jul 20;91(9-S):50-60. doi: 10.23750/abm.v91i9-S.10117.
9
Impact of COVID-19 on healthcare activity in NSW, Australia.2019冠状病毒病对澳大利亚新南威尔士州医疗活动的影响。
Public Health Res Pract. 2020 Dec 9;30(4):3042030. doi: 10.17061/phrp3042030.
10
SARS-CoV-2 indoor contamination: considerations on anti-COVID-19 management of ventilation systems, and finishing materials in healthcare facilities.SARS-CoV-2 室内污染:对医疗保健设施中通风系统和装修材料的抗 COVID-19 管理的考虑。
Ann Ig. 2021 Jul-Aug;33(4):381-392. doi: 10.7416/ai.2020.2396. Epub 2020 Dec 4.

引用本文的文献

1
A cross-sectional study on the response abilities of clinical and preventive medical students in public health emergency.突发公共卫生事件中临床与预防医学专业学生应对能力的横断面研究
Front Public Health. 2022 Dec 1;10:1017063. doi: 10.3389/fpubh.2022.1017063. eCollection 2022.
2
The Cost-Effectiveness of Tislelizumab Plus Chemotherapy for Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer.替雷利珠单抗联合化疗治疗局部晚期或转移性非鳞状非小细胞肺癌的成本效益
Front Pharmacol. 2022 Jul 22;13:935581. doi: 10.3389/fphar.2022.935581. eCollection 2022.